Genetic Impairment of Succinate Metabolism Disrupts Bioenergetic Sensing in Adrenal Neuroendocrine Cancer
P. Gupta, K. Strange, R. Telange, A. Guo, H. Hatch, A. Sobh, J. Elie, A. M. Carter, J. Totenhagen, C. Tan, Y. A. Sonawane, J. Neuzil, A. Natarajan, A. J. Ovens, J. S. Oakhill, T. Wiederhold, K. Pacak, H. K. Ghayee, L. Meijer, S. Reddy, J. A. Bibb
Abstract
Metabolic dysfunction mutations can impair energy sensing and cause cancer. Loss of function of mitochondrial TCA cycle enzyme, succinate dehydrogenase B (SDHB) results in various forms of cancer typified by pheochromocytoma (PC). Here we delineate a signaling cascade where the loss of SDHB induces the Warburg effect in PC tumors, triggers dysregulation of Ca2+ homeostasis, and aberrantly activates calpain and the protein kinase Cdk5, through conversion of its cofactor from p35 to p25. Consequently, aberrant Cdk5 initiates a cascade of phospho- signaling where GSK3 inhibition inactivates energy sensing by AMP-kinase through dephosphorylation of the AMP-kinase {gamma} subunit, PRKAG2. Overexpression of p25-GFP in mouse adrenal chromaffin cells also elicits this phosphorylation signaling and causes PC tumor formation. A novel Cdk5 inhibitor, MRT3-007, reversed this phospho-cascade, invoking an anti- Warburg effect, cell cycle arrest, and senescence-like phenotype. This therapeutic approach halted tumor progression in vivo. Thus, we reveal an important novel mechanistic feature of metabolic sensing and demonstrate that its dysregulation underlies tumor progression in PC and likely other cancers. HighlightsO_LILoss of SDHB function in pheochromocytoma causes Ca2+ dysregulation, calpain activation, and aberrant activation of the protein kinase Cdk5. C_LIO_LIHyperactive Cdk5 deregulates a GSK3/PRKAG2/AMPK signaling cascade. C_LIO_LIp25 overexpression and consequent aberrant Cdk5 activity in chromaffin cells causes pheochromocytoma. C_LIO_LIInhibition of Cdk5 activates the PRKAG2/AMPK/p53 signaling to rescue cell senescence and block PC tumor progression. C_LI Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=175 SRC="FIGDIR/small/475410v2_ufig1.gif" ALT="Figure 1"> View larger version (49K): org.highwire.dtl.DTLVardef@16f0a48org.highwire.dtl.DTLVardef@10c1c7aorg.highwire.dtl.DTLVardef@21b100org.highwire.dtl.DTLVardef@1eb8674_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SDHB deficiency silences ABCB1 expression and confers therapeutic vulnerability across multiple cancer types
Qianjin Guo, Anzel Zhen, … Justin P Annes·bioRxiv·Nov 3, 2026
- Succinate Dehydrogenase-Deficient Cancer Cells Have Increased Susceptibility to Ym155 Induced DNA Damage
Qianjin Guo, Sooyeon Lee, … Justin P. Annes·Endocrine Related CancerPeer-reviewed·Feb 19, 2026
- Distinct proteomic and acylproteomic adaptations to succinate dehydrogenase loss in two cell contexts
Sherry X. Zhou, Benjamin J. Madden, … Louis James Maher III·bioRxiv·Aug 1, 2025
- A Mathematical Exploration of SDH-b Loss in Chromaffin Cells
Elías Vera-Sigüenza, Himani Rana, … Daniel A. Tennant·Bulletin of Mathematical BiologyPeer-reviewed·Mar 13, 2025
- SIRT5 is the desuccinylase of LDHA as novel cancer metastatic stimulator in aggressive prostate cancer
O. K. Kwon, I. H. Bang, … S. Lee·bioRxiv·Aug 8, 2021
- TGF-B signaling suppresses TCA cycle metabolism in renal cancer.
H. Nam, A. Kundu, … S. Sudarshan·bioRxiv·Feb 19, 2021